10-K Filing

GLUCOSE HEALTH, INC. CIK: 1420108 FY 2015

Filing Information

Form Type	10-K
Accession Number	`0001477932-16-009786`
Period End Date	20151231
Filing Date	20160414
Fiscal Year	2015
Fiscal Period	FY
XBRL Instance	gluc-20151231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 62 Income Statement 38 Cash Flow Statement 49 Stockholders Equity 21

Balance Sheet 62 line items

Line Item	Tag	Value	Unit	Period
Net of accumulated amortization	`AccumulatedAmortizationOfNoncurrentDeferredFinanceCosts`	-	USD	Point-in-time
Net of accumulated amortization	`AccumulatedAmortizationOfNoncurrentDeferredFinanceCosts`	-	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1,000.00	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1,000.00	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$2.06K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$711.00	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$4.87K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	1,000.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	1,000.00	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$3.15K	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	-	USD	Point-in-time
Inventory	`InventoryNet`	$8.37K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	1,000.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	1,000.00	shares	Point-in-time
Inventory	`InventoryNet`	-	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Due from affiliate	`DueFromAffiliates`	$250.00	USD	Point-in-time
Due from affiliate	`DueFromAffiliates`	-	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$1.28K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$38.86K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	1.31M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	2.45M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$15.11K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$43.73K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	2.45M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	1.31M	shares	Point-in-time
Intellectual assets, net of accumulated amortization of $0 and $0, respectively	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$300.00	USD	Point-in-time
Intellectual assets, net of accumulated amortization of $0 and $0, respectively	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$300.00	USD	Point-in-time
TOTAL ASSETS	`Assets`	$44.03K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$15.41K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$94.92K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$154.66K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$7.75K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$6.08K	USD	Point-in-time
Convertible notes payable, related parties	`ConvertibleNotesPayableCurrent`	$23.93K	USD	Point-in-time
Convertible notes payable, related parties	`ConvertibleNotesPayableCurrent`	$100.83K	USD	Point-in-time
Convertible notes payable	`ConvertibleNotesPayable`	$138.25K	USD	Point-in-time
Convertible notes payable	`ConvertibleNotesPayable`	$201.40K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$403.23K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$324.58K	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$324.58K	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$403.23K	USD	Point-in-time
Preferred stock, $ no par value, 1,000 shares authorized, 1,000 shares issued and outstanding as of December 31, 2015 and December 31, 2014	`PreferredStockValue`	$113.20K	USD	Point-in-time
Preferred stock, $ no par value, 1,000 shares authorized, 1,000 shares issued and outstanding as of December 31, 2015 and December 31, 2014	`PreferredStockValue`	$113.20K	USD	Point-in-time
Common stock, $0.001 par value, 200,000,000 shares authorized, 2,451,888 and 1,309,825 shares issued and outstanding as of December 31, 2015 and December 31, 2014, respectively (1)	`CommonStockValue`	$2.45K	USD	Point-in-time
Common stock, $0.001 par value, 200,000,000 shares authorized, 2,451,888 and 1,309,825 shares issued and outstanding as of December 31, 2015 and December 31, 2014, respectively (1)	`CommonStockValue`	$1.31K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$5.39M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$5.23M	USD	Point-in-time
Stock subscription	`CommonStockSharesSubscriptions`	$23.00K	USD	Point-in-time
Stock subscription	`CommonStockSharesSubscriptions`	$23.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-75.28K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-75.28K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-5.84M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-5.57M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-387.82K	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-197.76K	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-280.55K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$44.03K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$15.41K	USD	Point-in-time

Income Statement 38 line items

Line Item	Tag	Value	Unit	Period
REVENUE	`SalesRevenueGoodsNet`	$2.74K	USD	Annual
REVENUE	`SalesRevenueGoodsNet`	$4.27K	USD	Annual
Cost of revenues	`CostOfRevenue`	$3.88K	USD	Annual
Cost of revenues	`CostOfRevenue`	$2.64K	USD	Annual
Inventory impairment	`OtherSalesRevenueNet`	-	USD	Annual
Inventory impairment	`OtherSalesRevenueNet`	$20.83K	USD	Annual
Total Cost of Revenues	`CostOfGoodsAndServicesSold`	$3.88K	USD	Annual
Total Cost of Revenues	`CostOfGoodsAndServicesSold`	$23.46K	USD	Annual
GROSS PROFIT/(LOSS)	`GrossProfit`	$397.00	USD	Annual
GROSS PROFIT/(LOSS)	`GrossProfit`	$-20.73K	USD	Annual
Professional fees/stock based compensation	`ProfessionalFees`	$504.19K	USD	Annual
Professional fees/stock based compensation	`ProfessionalFees`	$41.70K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$4.00K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$48.00	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$114.87K	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$16.30K	USD	Annual
Total operating expenses	`OperatingExpenses`	$524.49K	USD	Annual
Total operating expenses	`OperatingExpenses`	$156.57K	USD	Annual
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-156.17K	USD	Annual
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-545.22K	USD	Annual
Interest income (expense)	`InterestExpense`	$120.03K	USD	Annual
Interest income (expense)	`InterestExpense`	$109.63K	USD	Annual
Loss on conversion of debt	`DebtConversionOriginalDebtAmount1`	$-10.44K	USD	Annual
Loss on conversion of debt	`DebtConversionOriginalDebtAmount1`	$-14.56K	USD	Annual
Gain on forgiveness of accounts payable	`GainOnForgivenessOfAccountsPayable`	-	USD	Annual
Gain on forgiveness of accounts payable	`GainOnForgivenessOfAccountsPayable`	$20.57K	USD	Annual
Total other expense	`NonoperatingIncomeExpense`	$-124.19K	USD	Annual
Total other expense	`NonoperatingIncomeExpense`	$-109.89K	USD	Annual
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-669.41K	USD	Annual
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-266.06K	USD	Annual
PROVISION FOR (BENEFIT FROM) INCOME TAXES	`IncomeTaxExpenseBenefit`	-	USD	Annual
PROVISION FOR (BENEFIT FROM) INCOME TAXES	`IncomeTaxExpenseBenefit`	-	USD	Annual
NET LOSS	`NetIncomeLoss`	$-669.41K	USD	Annual
NET LOSS	`NetIncomeLoss`	$-266.06K	USD	Annual
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING BASIC AND DILUTED (2)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.96M	shares	Annual
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING BASIC AND DILUTED (2)	`WeightedAverageNumberOfSharesOutstandingBasic`	675,155.00	shares	Annual
NET LOSS PER SHARE - BASIC AND DILUTED	`EarningsPerShareBasic`	$-0.14	USD	Annual
NET LOSS PER SHARE - BASIC AND DILUTED	`EarningsPerShareBasic`	$-0.99	USD	Annual

Cash Flow Statement 49 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-669.41K	USD	Annual
Net loss	`NetIncomeLoss`	$-266.06K	USD	Annual
Inventory write down	`InventoryWriteDown`	$14.40K	USD	Annual
Inventory write down	`InventoryWriteDown`	-	USD	Annual
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$32.77K	USD	Annual
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$372.73K	USD	Annual
Amortization of note discount	`AmortizationOfDebtDiscountPremium`	$100.10K	USD	Annual
Amortization of note discount	`AmortizationOfDebtDiscountPremium`	$43.08K	USD	Annual
Gain on forgiveness of accounts payable	`IncreaseDecreaseINGainOnForgivenessOfAccountsPayable`	-	USD	Annual
Gain on forgiveness of accounts payable	`IncreaseDecreaseINGainOnForgivenessOfAccountsPayable`	-	USD	Annual
(Gain) loss on conversion of debt	`GainLossOnNonRecourseDebt`	-	USD	Annual
(Gain) loss on conversion of debt	`GainLossOnNonRecourseDebt`	$14.56K	USD	Annual
Beneficial conversion feature of notes payable	`DebtInstrumentConvertibleBeneficialConversionFeature`	-	USD	Annual
Beneficial conversion feature of notes payable	`DebtInstrumentConvertibleBeneficialConversionFeature`	$-109.54K	USD	Annual
Increase in accounts receivable	`IncreaseDecreaseInAccountsReceivable`	-	USD	Annual
Increase in accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$4.57K	USD	Annual
(Increase) decrease in inventory	`IncreaseDecreaseInInventories`	$8.37K	USD	Annual
(Increase) decrease in inventory	`IncreaseDecreaseInInventories`	$-10.48K	USD	Annual
Decrease in prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpense`	-	USD	Annual
Decrease in prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpense`	$-37.58K	USD	Annual
Increase (decrease) in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$21.79K	USD	Annual
Increase (decrease) in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-59.74K	USD	Annual
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$150.29K	USD	Annual
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$534.06K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-115.78K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-135.35K	USD	Annual
Increase in due from affilliate	`IncreaseDecreaseInAdvanceToAffiliate`	$-250.00	USD	Annual
Increase in due from affilliate	`IncreaseDecreaseInAdvanceToAffiliate`	-	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-250.00	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	Annual
Proceeds from notes and loans payable	`ProceedsFromNotesPayable`	$139.51K	USD	Annual
Proceeds from notes and loans payable	`ProceedsFromNotesPayable`	$113.21K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$139.51K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$113.21K	USD	Annual
NET INCREASE IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$4.16K	USD	Annual
NET INCREASE IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-2.82K	USD	Annual
CASH - BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$2.06K	USD	Point-in-time
CASH - BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$711.00	USD	Point-in-time
CASH - BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$4.87K	USD	Point-in-time
CASH - END OF PERIOD	`CashEquivalentsAtCarryingValue`	$4.87K	USD	Point-in-time
CASH - END OF PERIOD	`CashEquivalentsAtCarryingValue`	$2.06K	USD	Point-in-time
Beneficial conversion feature	`BeneficialConversionFeature`	-	USD	Annual
Beneficial conversion feature	`BeneficialConversionFeature`	$109.54K	USD	Annual
Conversion of notes payable and accrued interest to common stock	`DebtConversionConvertedInstrumentAmount1`	$4.10K	USD	Annual
Conversion of notes payable and accrued interest to common stock	`DebtConversionConvertedInstrumentAmount1`	$54.79K	USD	Annual
Cancellation for 600,000 shares of common stock to settle liabilities	`CancellationFor600000SharesOfCommonStockToSettleLiabilities`	21,000.00	shares	Annual
Cancellation for 600,000 shares of common stock to settle liabilities	`CancellationFor600000SharesOfCommonStockToSettleLiabilities`	-	shares	Annual
Conversion of liability to common stock	`StockIssued1`	$4.32K	USD	Annual
Conversion of liability to common stock	`StockIssued1`	-	USD	Annual

Stockholders Equity 21 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, Amount	`StockholdersEquity`	$-387.82K	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquity`	$-197.76K	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquity`	$-280.55K	USD	Point-in-time
Preferred shares issued for compensation under employment agreement, Amount	`PreferredSharesIssuedForCompensationUnderEmploymentAgreementAmount`	$113.20K	USD	Annual
Common shares issued for compensation under employment agreement, Amount	`CommonSharesIssuedForCompensationUnderEmploymentAgreementAmount`	$114.00K	USD	Annual
Common shares issued for services, Amount	`CommonSharesIssuedForServicesAmount`	$115.16K	USD	Annual
Common shares issued for liability for stock to be issued, Amount	`CommonSharesIssuedForLiabilityForStockToBeIssuedAmount`	$14.40K	USD	Annual
Common shares issued for settlement of notes payable, Amount	`CommonSharesIssuedForSettlementOfNotesPayableAmount`	$54.79K	USD	Annual
Common shares issued for Glucose Health Natural Blood Sugar Maintenance product acquisition, Amount	`CommonSharesIssuedForGlucoseHealthNaturalBloodSugarMaintenanceProductAcquisitionAmount`	$300.00	USD	Annual
Options issued for service	`OptionsIssuedForService`	$51.85K	USD	Annual
Discounts on shares issued for notes payable	`DiscountsOnSharesIssuedForNotesPayable`	$116.94K	USD	Annual
Stock to be issued	`StockToBeIssued`	$-11.40K	USD	Annual
Amortization of deferred compensation	`AmortizationOfDeferredCompensation`	$17.37K	USD	Annual
Factional shares issued, Amount	`FactionalSharesIssuedAmount`	-	USD	Annual
Common stock issued as compensation, amount	`CommonStockIssuedAsCompensationAmount`	$6.00K	USD	Annual
Net loss for the year	`NetIncomeLoss`	$-669.41K	USD	Annual
Net loss for the year	`NetIncomeLoss`	$-266.06K	USD	Annual
Common stock issued in satisfaction of debt, amount	`CommonStockIssuedInSatisfactionOfDebtAmount`	$16.48K	USD	Annual
Ending Balance, Amount	`StockholdersEquity`	$-387.82K	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquity`	$-197.76K	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquity`	$-280.55K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.